Press Releases
Suzhou Connect biopharmaceuticals, Ltd. (Suzhou Connect) was invited to participate in the 5th BIOCYTOGEN model animal and pharmaceutical industry conference

Taicang, Suzhou, China, April 21, 2019 -- Connect biopharma today announced that Dr. Wubin Pan, the company's cofounder and President, was invited to speak at the 5th BIOCYTOGEN Conference on Animal Models and Pharmaceutical Industry Held in Haimen, China from April 20-21, 2019.

At the conference, Dr. Pan delivered a speech entitled:  "Prospects for New Generation S1P1 Agonistic Immunomodulators in the Treatment of Ulcerative Colitis." The speech was well received.

The conference, focused on tumor immunity and autoimmunity, was attended by experts and scholars in the field of immunology in China and abroad to discuss the recent advances in immunotherapy and drug development.



TEL/FAX: 0512-53577866

E-MAIL: swlu@connectpharm.com

ADD: Science and Technology Park, East R&D Building , 3rd Floor , 6 Beijing West Road, Taichang, Jiangsu, China 215400

Copyright: Suzhou Connect Biopharmaceuticals, Ltd. 苏ICP备17002143号

Technical support: Epower